Fundz

Hemoshear Therapeutics, Inc. reported raising $43.1 Million in an initial SEC Form D filing, from an offering of $48.1 Million

PRIVATEFeb 18, 2021$43.1M of $48.1M raised

Amount Raised

$43.1 Million

$43.1 Million sold, per SEC Form D (first sale Feb 18, 2021)

Round Type

Venture

CharlottesvilleBiotechnology

Quick answer

HEMOSHEAR THERAPEUTICS, INC. raised $43.1 Million in a funding round, dated February 18, 2021. HEMOSHEAR THERAPEUTICS, INC. is based in Charlottesville, Virginia, United States.

How much did HEMOSHEAR THERAPEUTICS, INC. raise?
HEMOSHEAR THERAPEUTICS, INC. raised $43.1 Million in a funding round on February 18, 2021.
What does HEMOSHEAR THERAPEUTICS, INC. do?
HemoShear Therapeutics is a biotechnology company focused on discovering novel biological targets and developing drugs to treat children’s rare metabolic disorders.
Where is HEMOSHEAR THERAPEUTICS, INC. based and how big is it?
HEMOSHEAR THERAPEUTICS, INC. is based in Charlottesville, Virginia, United States.
Who are the decision-makers at HEMOSHEAR THERAPEUTICS, INC?
Fundz holds 1 contact at HEMOSHEAR THERAPEUTICS, INC., including the Executive Officer. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as HEMOSHEAR THERAPEUTICS, INC. that raised within 45 days of this round, from Fundz verified event records.

  • Kubanda Cryotherapy, Inc. raised $100K (Pre-Seed) on April 2, 2021.
  • Alloy Therapeutics raised $75M on April 2, 2021.
  • S4 Medical Corp. raised an undisclosed amount (Series A) on April 2, 2021.
  • Cellphire Therapeutics raised $15M (Series A) on April 2, 2021.
  • Alloy Therapeutics raised $75M (Series C) on April 2, 2021.
  • Stratix Labs Corp raised $786K (Seed) on April 2, 2021.

Who to call at HEMOSHEAR THERAPEUTICS, INC., and when

A new round usually means HEMOSHEAR THERAPEUTICS, INC. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day HEMOSHEAR THERAPEUTICS, INC. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at HEMOSHEAR THERAPEUTICS, INC., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at HEMOSHEAR THERAPEUTICS, INC.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

HEMOSHEAR THERAPEUTICS, INC.

Location

501 LOCUST AVENUE, SUITE 301

Charlottesville, Virginia, United States

About

HemoShear Therapeutics is a biotechnology company focused on discovering novel biological targets and developing drugs to treat children’s rare metabolic disorders. Our goal is to discover drugs that save the lives of children who are born with metabolic defects and are unable to sustain basic biochemical processes necessary for life. Our proprietary technology allows us to recapitulate diseases using tissue from livers of children born with genetic defects, interrogate the disrupted biochemical processes, explore drug intervention strategies, and select drug candidates that we believe have high probabilities of clinical success.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment HEMOSHEAR THERAPEUTICS, INC. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsBrian W., Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for HEMOSHEAR THERAPEUTICS, INC.'s next move

See what Strategic adds

HEMOSHEAR THERAPEUTICS, INC. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.